Spain has observed a 24.41 million (2.2%) increase in the research & development by business enterprise, pharmaceutical industry in constant ppp $, which now stands at 1,127.36 million.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Spain
No matching regions
Similar regions to Spain
Business R&D pharmaceutical in constant PPP $
More indicators for Spain
Government R&D in security as % of government support
0.9%
-0.24%
(2021)
Higher-education-finacing R&D financed by general university in local currency
23,184.87M
+764.87M
(2021)
R&D financed by rest of the world in local currency
12,856.55M
+696.55M
(2021)
Government R&D financed by rest of the world in local currency
2,777.25M
-132.75M
(2021)
Business R&D financed by rest of the world in local currency
6,827.05M
+637.05M
(2021)
Non-profit R&D growth rate
15.25%
-3.51%
(2022)
Spain Business R&D pharmaceutical in constant PPP $ between 2000 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 1,127.36M | +24.41M |
| 2020 | 1,102.95M | -31.28M |
| 2019 | 1,134.24M | +30.37M |
| 2018 | 1,103.87M | +70.97M |
| 2017 | 1,032.90M | +86.20M |
| 2016 | 946.69M | +54.12M |
| 2015 | 892.58M | +17.97M |
| 2014 | 874.61M | +17.29M |
| 2013 | 857.32M | -31.90M |
| 2012 | 889.22M | -72.66M |
| 2011 | 961.88M | +10.24M |
| 2010 | 951.65M | -55.14M |
| 2009 | 1,006.79M | +24.46M |
| 2008 | 982.33M | +23.77M |
| 2007 | 958.56M | -19.29M |
| 2006 | 977.85M | +64.72M |
| 2005 | 913.13M | +76.16M |
| 2004 | 836.97M | +2.01M |
| 2003 | 834.95M | +70.75M |
| 2002 | 764.20M | +132.74M |
| 2001 | 631.46M | +151.57M |
| 2000 | 479.90M |